We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-4.33%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$420M
AUM Growth
+$69.1M
Cap. Flow
+$105M
Cap. Flow %
24.98%
Top 10 Hldgs %
47.86%
Holding
226
New
142
Increased
26
Reduced
23
Closed
35

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$23.7M
2
DHR icon
Danaher
DHR
+$22.7M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18M
5
CCI icon
Crown Castle
CCI
+$17.5M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$33.7M
2
ELV icon
Elevance Health
ELV
+$27.6M
3
KO icon
Coca-Cola
KO
+$25.4M
4
NVO
Novo Nordisk
NVO
+$25.3M
5
EOG icon
EOG Resources
EOG
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Technology 23.66%
3 Consumer Staples 13.55%
4 Financials 10.55%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMN icon
176
Eastman Chemical
EMN
$7.8B
$2.35K ﹤0.01%
+33
New +$2.97K
BSV icon
177
Vanguard Short-Term Bond ETF
BSV
$44.6B
$2.32K ﹤0.01%
+31
New +$2.37K
CMCSA icon
178
Comcast
CMCSA
$79.1B
$1.99K ﹤0.01%
68
-10,304
-99% -$385K
GSY icon
179
Invesco Ultra Short Duration ETF
GSY
$3.82B
$1.98K ﹤0.01%
+40
New +$1.98K
MYGN icon
180
Myriad Genetics
MYGN
$530M
$1.91K ﹤0.01%
+100
New +$2.29K
SPOT icon
181
Spotify
SPOT
$99.2B
$1.73K ﹤0.01%
+20
New +$2.14K
VONG icon
182
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
$1.68K ﹤0.01%
+31
New +$1.88K
CNCE
183
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.34K ﹤0.01%
+200
New +$1.21K
FLOT icon
184
iShares Floating Rate Bond ETF
FLOT
$10.1B
$1.26K ﹤0.01%
+25
New +$1.25K
IUSB icon
185
iShares Core Universal USD Bond ETF
IUSB
$42.6B
$1.02K ﹤0.01%
+23
New +$1.07K
EPR icon
186
EPR Properties
EPR
$4.86B
$968 ﹤0.01%
+27
New +$1.27K
HLN icon
187
Haleon
HLN
$43.1B
$609 ﹤0.01%
+100
New +$647
FBRT
188
Franklin BSP Realty Trust
FBRT
$601M
$517 ﹤0.01%
+48
New +$660
NVO
189
Novo Nordisk
NVO
$216B
$299 ﹤0.01%
6
-471,702
-100% -$25.3M
BYND icon
190
Beyond Meat
BYND
$288M
$283 ﹤0.01%
+20
New +$552
AGEN
191
Agenus
AGEN
$249M
$205 ﹤0.01%
+5
New +$255
ADSK icon
192
Autodesk
ADSK
$44.3B
– –
-3,002
Closed -$516K
AEP icon
193
American Electric Power
AEP
$73.7B
– –
-2,810
Closed -$270K
ALB icon
194
Albemarle
ALB
$13.5B
– –
-1,640
Closed -$343K
ASML icon
195
ASML
ASML
$675B
– –
-559
Closed -$266K
BOX icon
196
Box
BOX
$4.02B
– –
-14,282
Closed -$359K
CAT icon
197
Caterpillar
CAT
$409B
– –
-6,737
Closed -$1.2M
COIN icon
198
Coinbase
COIN
$41.7B
– –
-17,587
Closed -$827K
D icon
199
Dominion Energy
D
$62.5B
– –
-5,498
Closed -$439K
DE icon
200
Deere & Co
DE
$170B
– –
-674
Closed -$202K
6 7
8
9 10

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q3 2022 Portfolio in Review

As of Q3 2022, De Burlo Group held 226 positions worth $420M, up 20% from $351M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

De Burlo Group deployed $105M of net new capital in Q3 2022, opening 142 new positions and adding to 26 existing holdings. Its largest new stake was Danaher: 92,796 shares worth $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Coca-Cola, an estimated $25.4M trimmed.

  • De Burlo Group's largest Q3 2022 buy was Danaher: 92,796 shares worth $21.2M.
  • De Burlo Group added most to UnitedHealth in Q3 2022, an estimated $23.7M increase.
  • De Burlo Group's biggest Q3 2022 reduction was Coca-Cola, cutting an estimated $25.4M.
  • De Burlo Group fully exited McKesson in Q3 2022, selling an estimated $33.7M.
  • De Burlo Group's ten largest holdings make up 48% of its $420M portfolio in Q3 2022.
  • De Burlo Group opened 142 new positions and closed 35 in Q3 2022.
  • De Burlo Group's portfolio value rose 20% quarter-over-quarter to $420M.

Based on De Burlo Group's 13F filing for Q3 2022, filed 14 Nov 2022.